Bio-Rad Reports First-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
Bio-Rad Labs (BIO) Tops Q1 EPS by $2.21
April 29, 2021 4:18 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $5.21, $2.21 better than the analyst estimate of $3.00. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $660.98 million.
2021 Financial Outlook
For the full year 2021, the company has updated its guidance and now anticipates non-GAAP... More
